FLGC vs. GLTO, BIVI, KALA, NRBO, GLYC, NNVC, APM, ORGS, TCRT, and NRSN
Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Galecto (GLTO), BioVie (BIVI), KALA BIO (KALA), NeuroBo Pharmaceuticals (NRBO), GlycoMimetics (GLYC), NanoViricides (NNVC), Aptorum Group (APM), Orgenesis (ORGS), Alaunos Therapeutics (TCRT), and NeuroSense Therapeutics (NRSN). These companies are all part of the "pharmaceutical preparations" industry.
Flora Growth (NASDAQ:FLGC) and Galecto (NASDAQ:GLTO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, community ranking, valuation and earnings.
Flora Growth has a beta of 2, meaning that its share price is 100% more volatile than the S&P 500. Comparatively, Galecto has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.
In the previous week, Flora Growth had 10 more articles in the media than Galecto. MarketBeat recorded 10 mentions for Flora Growth and 0 mentions for Galecto. Flora Growth's average media sentiment score of 0.26 beat Galecto's score of 0.00 indicating that Flora Growth is being referred to more favorably in the media.
Galecto has lower revenue, but higher earnings than Flora Growth.
Galecto has a net margin of 0.00% compared to Flora Growth's net margin of -75.95%. Galecto's return on equity of -87.11% beat Flora Growth's return on equity.
36.0% of Flora Growth shares are held by institutional investors. Comparatively, 14.2% of Galecto shares are held by institutional investors. 17.6% of Flora Growth shares are held by insiders. Comparatively, 12.1% of Galecto shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Flora Growth currently has a consensus target price of $6.00, suggesting a potential upside of 358.02%. Galecto has a consensus target price of $5.33, suggesting a potential upside of 758.69%. Given Galecto's higher possible upside, analysts clearly believe Galecto is more favorable than Flora Growth.
Galecto received 16 more outperform votes than Flora Growth when rated by MarketBeat users. However, 60.87% of users gave Flora Growth an outperform vote while only 58.82% of users gave Galecto an outperform vote.
Summary
Flora Growth beats Galecto on 9 of the 14 factors compared between the two stocks.
Get Flora Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Flora Growth Competitors List
Related Companies and Tools